TuHura Biosciences News and Activities

TuHura Biosciences is a company listed under the stock ticker HURA (US).

Acquisition, funding and merger involving TuHura Biosciences.

• Kineta and TuHura Biosciences have merged  (posted on December 13 2024)..
• TuHura Biosciences and Kintara Therapeutics have merged  (posted on October 20 2024)..
• Kintara Therapeutics and TuHura Biosciences have merged  (posted on September 10 2024)..

View the org chart displaying its 14 main executives

Most searched biographies at TuHura Biosciences

• James Bianco, President and Chief Executive Officer
• George Ng, Director
• Alan List, Director

Popular executive movements at TuHura Biosciences

• Craig Tendler who was Director, becomes Chief Medical Officer  (posted on March 24 2026).

Create your alert
to follow the executive moves at TuHura Biosciences.

TuHura Biosciences has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by TuHura Biosciences

• TuHURA Biosciences News powered by B2i Technologies - SmartWireTuHURA Biosciences News powered by B2i Technologies - SmartWire
• Press Releases - TuHURA

Social media about TuHura Biosciences

• TuHura Biosciences on Wikipedia, Google News & Yahoo Finance
• TuHura Biosciences on LinkedIn, X (Twitter) & YouTube